CH5164840 (16) shows high binding affinity for N-terminal Hsp90a (K d = 0.52 nM) and strong anti-proliferative activity against human cancer cell lines (HCT116 IC 50 = 0.15 μM, NCI-N87 IC 50 = 0.066 μM). CH5164840 (16) is orally active (t 1/2 = 2.64 h) with potent antitumor efficacy.
Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HSP
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.